Gary D Steinberg Selected Research

Urinary Diversion (Ileal Conduit)

5/2018	Perioperative and long-term outcomes after radical cystectomy in hemodialysis patients.
1/2018	Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort.
1/2017	Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade.
3/2016	The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy.
2/2015	The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy.
1/2015	Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device.
10/2014	Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion.
4/2014	Cystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes.
9/2013	The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.
11/2012	The impact of mechanical bowel preparation on postoperative complications for patients undergoing cystectomy and urinary diversion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary D Steinberg Research Topics

Disease

36	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2008
32	Neoplasms (Cancer) 01/2024 - 11/2005
21	Non-Muscle Invasive Bladder Neoplasms 01/2024 - 09/2011
7	Carcinoma (Carcinomatosis) 11/2023 - 09/2014
7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 08/2003
7	Pathologic Constriction (Stenosis) 01/2017 - 10/2002
5	Carcinoma in Situ 11/2023 - 05/2011
5	Hemorrhage 01/2017 - 11/2002
4	Fistula 01/2018 - 11/2002
3	Ileus 04/2017 - 06/2014
3	Margins of Excision 01/2017 - 12/2006
3	Infections 03/2016 - 10/2003
3	Adenocarcinoma 08/2013 - 08/2003
2	COVID-19 12/2023 - 10/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2018
2	Lymphatic Metastasis 01/2020 - 01/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 11/2002
2	Wounds and Injuries (Trauma) 01/2017 - 11/2012
2	Hematuria 08/2006 - 08/2003
2	Flank Pain 09/2004 - 10/2003
1	Residual Neoplasm 01/2022
1	Tuberculosis (Tuberculoses) 10/2021
1	Thrombosis (Thrombus) 11/2019
1	Kidney Neoplasms (Kidney Cancer) 11/2019
1	Penile Neoplasms (Penile Cancer) 12/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2018
1	Intestinal Obstruction (Obstruction, Intestinal) 04/2017
1	Venous Thromboembolism 01/2017
1	Thromboembolism 01/2017
1	Contracture 09/2015
1	Heart Failure 01/2015

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2016
3	alvimopan FDA Link 04/2017 - 06/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 04/2011 - 11/2007
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
2	Cancer VaccinesIBA 01/2024 - 02/2022
2	Complementary DNA (cDNA)IBA 01/2021 - 08/2003
2	PlatinumIBA 12/2020 - 12/2016
2	NivolumabIBA 01/2020 - 11/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2019 - 10/2015
2	Cadherins (E-Cadherin)IBA 09/2014 - 01/2012
2	valrubicin (AD 32)FDA Link 11/2013 - 05/2011
2	MetalsIBA 11/2006 - 09/2004
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	pembrolizumabIBA 11/2023
1	cyclopropapyrroloindoleIBA 11/2023
1	atezolizumabIBA 01/2023
1	Peptides (Polypeptides)IBA 02/2022
1	Gemcitabine FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	EpitopesIBA 11/2021
1	VaccinesIBA 10/2021
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2021
1	ClaudinsIBA 12/2020
1	Phenobarbital (Luminal)FDA Link 12/2020
1	Mesylates (Mesylate)IBA 01/2020
1	linrodostatIBA 01/2020
1	IpilimumabIBA 11/2019
1	Sunitinib (Sutent)FDA Link 11/2019
1	Capecitabine (Xeloda)FDA Link 02/2019
1	Fluorouracil (Carac)FDA LinkGeneric 02/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2017
1	1- (2- chloroethyl)- 3- (2,6- dioxo- 3- piperidinyl)- 1- nitrosoureaIBA 01/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017
1	Pregnenolone Carbonitrile (PCN)IBA 01/2017
1	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 03/2016
1	OzoneIBA 02/2016
1	Nucleic AcidsIBA 02/2016

Therapy/Procedure

45	Cystectomy 12/2023 - 10/2002
25	Therapeutics 01/2024 - 01/2010
17	Urinary Diversion (Ileal Conduit) 05/2018 - 10/2002
10	Immunotherapy 01/2024 - 01/2013
9	Transurethral Resection of Bladder 01/2024 - 06/2014
9	Radiotherapy 02/2019 - 10/2005
7	Drug Therapy (Chemotherapy) 12/2020 - 03/2009
7	Prostatectomy (Retropubic Prostatectomy) 01/2019 - 10/2005
6	Length of Stay 04/2017 - 11/2009
5	Nephrectomy 06/2008 - 11/2002
4	Neoadjuvant Therapy 01/2022 - 05/2009
3	Operative Time 12/2011 - 07/2007
3	Stents 11/2006 - 10/2003
2	Aftercare (After-Treatment) 01/2024 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 12/2018 - 01/2017
2	Total Parenteral Nutrition 03/2016 - 06/2014
2	Minimally Invasive Surgical Procedures 11/2009 - 06/2007
2	Nephrotomy 09/2004 - 10/2003
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Salvage Therapy 01/2021
1	Chemoradiotherapy 02/2019
1	Renal Dialysis (Hemodialysis) 05/2018
1	Replantation 01/2017
1	Nephroureterectomy 01/2017
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2016
1	Sternotomy 03/2016
1	Conservative Treatment 10/2015
1	Heart-Assist Devices 01/2015